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Increasing attention has been paid to the proposition that critical illness may have adverse implications for neurocognitive functioning and may play a significant causal role in the development of incident neurocognitive impairment in adults, 1 which may adversely affect their functional status and quality of life. Data are beginning to accumulate in survivors of the pediatric intensive care unit (PICU) suggesting that these patients also experience significant neurocognitive and functional morbidity after critical illness and intensive care unit (ICU) treatment. 2 Data in patients treated in the newborn ICU support this finding. For example, infants with very low birth weight (< 1,500 g) treated in the ICU have neurosensory deficits, neurocognitive impairments, poor academic achievement and other behavioral disorders years after ICU discharge. 3 While research is limited and there are major gaps in our knowledge, the investigations to date using validated rating scales suggest that substantial numbers of critically ill pediatric patients treated in the PICU develop unfavorable neurocognitive and functional morbidity.
Alievi and colleagues in this issue assessed neurocognitive and functional outcomes of 443 PICU survivors. 4 Outcomes were assessed at PICU admission and discharge using the pediatric cerebral performance category (PCPC) and the pediatric overall performance category (POPC) scales, modified from scales that assess brain injury in adult populations. 5 The POPC scale quantifies overall functional (general adaptive/physical morbidity) and the PCPC scale quantifies neurocognitive impairment. 2 The POPC and PCPC are sixpoint scales that rate increasing disability from normal function to death. The scores for the PCPC are 1 = normal, 2 = mild disability, 3 = moderate disability, 4 = severe disability, 5 = coma or vegetative state, and 6 = brain death and the scores for the POPC are 1 = good overall performance, 2 = mild overall disability, 3 = moderate overall disability, 4 = severe overall disability, 5 = coma or vegetative state, 6 = brain death (see Fisher et al. 2 for a detailed description).
Alievi at al. 4 found that patients' median PCPC at ICU admission was normal but declined to mild disability at PICU (36.3%) scores declined on the POPC indicating that critical illness and PICU treatment contributed to significant decline in neurocognitive and functional performance in these patients. Data addressing the ecological validity (real world impact) of neurocognitive and functional morbidity comes from one study that assessed outcomes using the same rating scales which found that patients with mild to moderate disability at PICU discharge had poor neurocognitive performance at school (e.g., requiring special education classrooms) and the functional impairments adversely affected their competitive performance at school. cantly to our inability to achieve normal growth rates in these infants. Indeed, most centers still report that close to 100% of preterm infants are growth restricted and SGA by term gestation.
